Literature DB >> 9988434

Allergic eye disease--a clinical challenge.

R J Buckley1.   

Abstract

Currently, six basic allergic eye diseases are recognized. In seasonal (SAC) and perennial allergic conjunctivitis (PAC), the allergic response is mediated predominantly by mast cells, whereas the more severe conditions, vernal (VKC) and atopic keratoconjunctivitis (AKC) and giant papillary conjunctivitis (GPC), are associated with a preponderance of T cells. Acute allergic conjunctivitis (AAC) occurs when a large quantity of allergen inoculates the eye and is usually self-limiting. SAC, the most common ocular allergy, is the ocular component of hayfever. PAC in the UK is most commonly caused by the house-dust mite (HDM); diagnosis is confirmed by skin-prick tests, eosinophils in the conjunctival smear, and raised tear or serum total IgE. SAC and PAC can usually be managed with chromone eyedrops and antihistamines. VKC usually presents in children under 10 years of age and mainly affects boys. Sufferers frequently have a personal or family history of atopy. Corneal involvement can occur in VKC, making it potentially sight-threatening. AKC occurs in atopic adults, and like VKC it affects the cornea. VKC and AKC require steroid treatment under specialist supervision; minimization of the steroid dose can often be achieved with use of a chromone. GPC occurs due to repeated contact of the conjunctival surface with a foreign surface, such as contact lenses. Attention to lens hygiene or switching to different lenses and treatment with a chromone are frequently effective. In all allergic eye diseases contact with the precipitating allergen should be avoided as far as possible.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9988434     DOI: 10.1046/j.1365-2222.1998.0280s6039.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  6 in total

Review 1.  Overview of ocular allergy treatment.

Authors:  M Friedlaender
Journal:  Curr Allergy Asthma Rep       Date:  2001-07       Impact factor: 4.806

2.  Demographic study of paediatric allergic conjunctivitis within a multiethnic patient population.

Authors:  A J Singh; R S K Loh; J A Bradbury
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

3.  Fyn regulates eosinophil infiltration into the conjunctiva by downregulating the Th2 response.

Authors:  Atsuki Fukushima; Tomoko Yamaguchi; Akemi Ozaki; Taketoshi Taniguchi; Keiko Udaka; Hisayuki Ueno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

4.  Quantification of tear proteins and sPLA2-IIa alteration in patients with allergic conjunctivitis.

Authors:  Kaijun Li; Xialin Liu; Ziyan Chen; Qiang Huang; Kaili Wu
Journal:  Mol Vis       Date:  2010-10-14       Impact factor: 2.367

5.  Long-term outcomes and risk factors for failure of glaucoma filtering surgery in eyes with vernal keratoconjunctivitis and steroid-induced glaucoma.

Authors:  Sirisha Senthil; Harsha L Rao; Mohammed Hasnat Ali; Rashmi Krishnamurthy; Siddharth Dikshit; Nikhil Choudhari; Ramyasri Sastry; Chandrashekar Garudadri
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 2.969

6.  Steroid-induced ocular hypertension in Asian children with severe vernal keratoconjunctivitis.

Authors:  Marcus Ang; Seng-Ei Ti; Raymond Loh; Sonal Farzavandi; Rongli Zhang; Donald Tan; Cordelia Chan
Journal:  Clin Ophthalmol       Date:  2012-08-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.